Dr Brett Stringer
(BMedSc, MBBS, PhD)
Brain Cancer Research Fellow, Flinders Health and Medical Research Institute (FHMRI)
Dr Brett Stringer is the Brain Cancer Research Fellow at Flinders University. He has co-authored more than 50 original research reports, mostly on brain cancer. His achievements include the co-establishment of a brain tumour biobank and a widely shared, extensively characterised, collection of brain cancer cell lines (QCell), in addition to work that helped lead to the clinical trial of a new therapy (Ifabotuzumab) for glioblastoma.
The goal of his current research is to identify novel pharmacologically amenable ways to treat malignant brain tumours by identifying dependencies created by the tumour microenvironment as well as by the genetic events that lead to the development of brain tumours. He works with Assoc Prof Simon Conn at Flinders University and Assoc Prof Cedric Bardy at the South Australian Health and Medical Research Institute (SAHMRI).
Current Projects & Areas of Interest:
The effect of cerebrospinal fluid on the phenotype of brain cancer
The role of circular RNA in brain cancer
The transcriptomic changes that underlie the development of brain cancer